Literature DB >> 5464392

Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host.

S B Halstead, P Simasthien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5464392      PMCID： PMC2591694     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  16 in total

1.  TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER.

Authors:  D E CAREY; R M MYERS; F M RODRIGUES
Journal:  Am J Trop Med Hyg       Date:  1965-05       Impact factor: 2.345

2.  ANTIGENIC VARIANTS OF ARBOVIRUSES. I. THE HOST AS A DETERMINANT IN THE EVOLVEMENT OF STRAIN VARIANTS.

Authors:  J R HENDERSON; H H SHAH; R C WALLIS
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

3.  RAPID TYPING OF DENGUE VIRUSES BY THE MICRO-PRECIPITIN AGAR-GEL DIFFUSION TECHNIQUE.

Authors:  Y C CHAN
Journal:  Nature       Date:  1965-04-03       Impact factor: 49.962

Review 4.  Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal.

Authors:  K M Johnson; S B Halstead; S N Cohen
Journal:  Prog Med Virol       Date:  1967

5.  Application of immunodiffusion methods to the antigenic analysis of dengue viruses. I. Precipitation-in-gel double diffusion in two imensions.

Authors:  A N Ibrahim; W M Hammon
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

6.  Dengue virus identification by the plaque reduction neutralization test.

Authors:  P K Russell; A Nisalak
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

7.  Differentiation of arboviruses by immunoelectrophoresis.

Authors:  R R Cuadrado; J Casals
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

8.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse.

Authors:  A C Sartorelli; D S Fischer; W G Downs
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

9.  Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons.

Authors:  S B Halstead; S Udomsakdi; P Singharaj; A Nisalak
Journal:  Am J Trop Med Hyg       Date:  1969-11       Impact factor: 2.345

10.  Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever.

Authors:  S Nimmannitya; S B Halstead; S N Cohen; M R Margiotta
Journal:  Am J Trop Med Hyg       Date:  1969-11       Impact factor: 2.345
View more
  42 in total

1.  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.

Authors:  C A King; J S Marshall; H Alshurafa; R Anderson
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Authors:  Claire Y-H Huang; Siritorn Butrapet; Kiyotaka R Tsuchiya; Natth Bhamarapravati; Duane J Gubler; Richard M Kinney
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Dengue virus infection of mast cells triggers endothelial cell activation.

Authors:  Michael G Brown; Laura L Hermann; Andrew C Issekutz; Jean S Marshall; Derek Rowter; Ayham Al-Afif; Robert Anderson
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

4.  Revealing the microscale spatial signature of dengue transmission and immunity in an urban population.

Authors:  Henrik Salje; Justin Lessler; Timothy P Endy; Frank C Curriero; Robert V Gibbons; Ananda Nisalak; Suchitra Nimmannitya; Siripen Kalayanarooj; Richard G Jarman; Stephen J Thomas; Donald S Burke; Derek A T Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

5.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.

Authors:  Claire Y-H Huang; Shawn J Silengo; Melissa C Whiteman; Richard M Kinney
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  NS 1 gene sequences from eight dengue-2 viruses and their evolutionary relationships with other dengue-2 viruses.

Authors:  J Blok; A J Gibbs; S M McWilliam; U T Vitarana
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.

Authors:  R Anderson; S Wang; C Osiowy; A C Issekutz
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  A lipid inhibitor of dengue virus in human colostrum and milk; with a note on the absence of anti-dengue secretory antibody.

Authors:  W A Falkler; A R Diwan; S B Halstead
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

10.  Clinical and laboratory studies on haemorrhagic fever in Burma, 1970-72.

Authors:  C Khai Ming; S Thain; U Thaung; K S Myint; T Swe; S B Halstead; A R Diwan
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.